Biotech & Medical Venture Deals Roundup
by Adam Rubenstein
Cylene Pharmaceuticals (San Diego, CA) a small molecule oncology drug discovery and development company closed a$44M Series C financing. The round was led by HBM BioVentures and Lilly Ventures.
Vertiflex (Carlsbad, CA) a developer of medical devices for spinal surgery raised a $20M Series B round. Participants included Alta Partners, Aberdare Ventures and Morgenthaler Ventures.
Avestha (India) developer of bioactive nutraceuticals closed a €25M Series C financing. The round was led by Fidelity International, Limagrain Group (France), Danone Group (France) and Bennett, Coleman (India).
Xcellerex (Marlborough, MA) a bioprocess and biologics manufacturer raised $11M in the second closing of a Series B financing, the total raised in the round was $20M. The round was led by the SCG Group and Kleiner Perkins Caufield & Byers.
Tigris Pharmaceuticals (Bonita, FL) developer of oncology therapies raised approximately $16M in a Series B financing. The round was led by NGN Capital along with Wexford Capital and Bushido Capital Partners.
Glucon (Boulder, CO) developer of a blood glucose measurement system raised an undisclosed amount of Series D funding. The deal was led by the 3i Group and was joined by Sequel Venture Partners, Quest Capital Partnership, Hunt Ventures and previous investors Aurum Ventures, Giza Venture Capital, MKI, Infinity Venture Capital Fund and Ascend Technology Ventures.
Blue Heron Biotechnology (Bothell, WA) a provider of gene synthesis services raised approximately $3.7M in Series D funding. Participants include Crabtree Ventures, Integra Ventures and Invitrogen.
PREVIOUS VENTURE DEAL ROUNDUPS:
- February 03, 2007
- January 20 2006
- December 16, 2006
- December 09, 2006
____________________
Cylene Pharmaceuticals (San Diego, CA) a small molecule oncology drug discovery and development company closed a$44M Series C financing. The round was led by HBM BioVentures and Lilly Ventures.
Vertiflex (Carlsbad, CA) a developer of medical devices for spinal surgery raised a $20M Series B round. Participants included Alta Partners, Aberdare Ventures and Morgenthaler Ventures.
Avestha (India) developer of bioactive nutraceuticals closed a €25M Series C financing. The round was led by Fidelity International, Limagrain Group (France), Danone Group (France) and Bennett, Coleman (India).
Xcellerex (Marlborough, MA) a bioprocess and biologics manufacturer raised $11M in the second closing of a Series B financing, the total raised in the round was $20M. The round was led by the SCG Group and Kleiner Perkins Caufield & Byers.
Tigris Pharmaceuticals (Bonita, FL) developer of oncology therapies raised approximately $16M in a Series B financing. The round was led by NGN Capital along with Wexford Capital and Bushido Capital Partners.
Glucon (Boulder, CO) developer of a blood glucose measurement system raised an undisclosed amount of Series D funding. The deal was led by the 3i Group and was joined by Sequel Venture Partners, Quest Capital Partnership, Hunt Ventures and previous investors Aurum Ventures, Giza Venture Capital, MKI, Infinity Venture Capital Fund and Ascend Technology Ventures.
Blue Heron Biotechnology (Bothell, WA) a provider of gene synthesis services raised approximately $3.7M in Series D funding. Participants include Crabtree Ventures, Integra Ventures and Invitrogen.
PREVIOUS VENTURE DEAL ROUNDUPS:
- February 03, 2007
- January 20 2006
- December 16, 2006
- December 09, 2006
____________________
posted by Nico at
11:54 AM
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home